NASDAQ:CDTX
Cidara Therapeutics, Inc.
- Stock
Last Close
12.95
30/08 20:00
Market Cap
51.64M
Beta: 1.34
Volume Today
40.58K
Avg: 3.19M
PE Ratio
−1.95
PFCF: −2.35
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -160.50K - | -160.50K 0% | -2.77M 1,627.73% | -2.77M 0% | -1.30M 53.25% | -1.30M 0% | 3.05M 335.13% | |||||
average payables | 604.50K - | 2.14M 253.35% | 3.00M 40.54% | 2.75M 8.41% | 2.72M 1.15% | 2.37M 12.93% | 3.23M 36.38% | 2.93M 9.08% | 1.37M 53.18% | 2.61M 89.92% | ||
average receivables | 160.50K - | 160.50K 0% | 2.77M 1,627.73% | 8.36M 201.50% | 8.27M 1.14% | 5.59M 32.32% | 11.04M 97.33% | |||||
book value per share | -0.46 - | 1.66 464.51% | 10.47 530.08% | 6.09 41.90% | 3.41 43.91% | 2.29 33.04% | 1.26 44.71% | 0.26 79.60% | 0.41 59.51% | -0.04 110.11% | ||
capex per share | -0.08 - | -0.12 51.07% | -0.03 76.53% | -0.02 36.82% | -0.01 60.87% | -0.00 82.91% | -0.00 282.80% | -0.00 82.54% | -0.00 116.10% | |||
capex to depreciation | -5.54 - | -2.54 54.16% | -0.55 78.42% | -0.46 16.25% | -0.34 26.23% | -0.09 72.42% | -0.81 770.24% | 0.03 104.10% | -0.10 388.98% | |||
capex to operating cash flow | 0.13 - | 0.05 64.93% | 0.01 77.63% | 0.01 39.19% | 0.00 49.09% | 0.00 60.70% | 0.00 178.67% | 0.00 52.47% | 0.00 155.04% | |||
capex to revenue | -0.00 - | -0.02 821.09% | -0.00 94.63% | -0.00 121.92% | ||||||||
cash per share | 0.06 - | 1.80 2,875.48% | 15.37 755.83% | 8.55 44.37% | 5.13 39.97% | 2.88 43.84% | 2.01 30.15% | 0.86 57.08% | 1.19 37.38% | 0.47 60.53% | ||
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 96.79 - | 338.02 249.24% | 39.44 88.33% | 33.12 16.02% | ||||||||
debt to assets | 7.38 - | 0.09 - | 0.12 36.43% | 0.13 0.46% | 0.17 35.46% | 0.13 22.48% | 0.07 49.01% | 0.03 58.81% | 0.07 162.93% | |||
debt to equity | -1.06 - | 0.11 - | 0.17 48.79% | 0.17 1.59% | 0.31 84.60% | 0.74 139.78% | 0.23 68.43% | -0.45 293.31% | -0.59 30.98% | |||
dividend yield | ||||||||||||
earnings yield | -0.03 - | -0.06 113.70% | -0.19 222.93% | -0.32 69.02% | -0.47 46.50% | -0.97 107.30% | -0.35 64.08% | -0.87 149.70% | -0.66 24.30% | -0.56 14.43% | ||
enterprise value | 50.34M - | 180.31M 258.16% | 62.72M 65.22% | 55.86M 10.94% | 53.56M 4.11% | -3.84M 107.17% | 66.41M 1,829.92% | 55.16M 16.93% | 9.40M 82.95% | 21.42M 127.77% | -30.90M 244.27% | |
enterprise value over ebitda | -46.53 - | -21.91 52.91% | -1.94 91.14% | -1.15 40.58% | -0.96 16.65% | 0.06 105.95% | -1.58 2,856.38% | -0.77 51.13% | -0.22 71.11% | -0.72 223.86% | ||
ev to operating cash flow | -48.04 - | -23.39 51.32% | -2.42 89.67% | -1.40 41.87% | -1.07 23.59% | 0.07 106.31% | -2.33 3,538.08% | -1.01 56.44% | -0.37 63.24% | -0.75 101.85% | ||
ev to sales | 3.18 - | 4.57 43.98% | 0.19 95.85% | 0.33 75.63% | ||||||||
free cash flow per share | -0.34 - | -0.69 100.48% | -2.73 298.97% | -2.77 1.39% | -2.87 3.49% | -2.20 23.37% | -0.95 56.60% | -1.31 37.67% | -0.48 63.33% | -0.41 15.06% | ||
free cash flow yield | -0.02 - | -0.04 100.48% | -0.16 272.00% | -0.27 67.29% | -0.42 58.28% | -0.94 121.74% | -0.25 73.44% | -0.66 164.32% | -0.38 42.25% | -0.54 42.64% | ||
graham net net | -0.46 - | 1.54 433.85% | 14.76 858.30% | 7.25 50.85% | 4.03 44.38% | 2.11 47.70% | 1.02 51.69% | -0.13 112.78% | 0.21 264.45% | -0.19 189.45% | ||
graham number | 2.12 - | 5.92 179.10% | 27.66 367.14% | 21.34 22.85% | 15.64 26.70% | 10.83 30.74% | 6.17 43.03% | 3.18 48.49% | 2.78 12.44% | 0.63 77.31% | ||
income quality | 0.78 - | 0.65 16.87% | 0.81 24.39% | 0.83 2.40% | 0.90 8.46% | 0.96 7.29% | 0.69 27.74% | 0.75 8.67% | 0.59 21.26% | 0.96 60.82% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -269.27 - | -178.73 33.63% | 7.96K 4,553.71% | -100.61 101.26% | -188.80 87.65% | 274.23 245.25% | -199.32 172.68% | -155.59 21.94% | ||||
interest debt per share | 0.48 - | 0.01 - | 0.69 5,642.79% | 0.56 18.85% | 0.41 27.61% | 0.40 2.21% | 0.19 53.57% | 0.10 45.74% | 0.02 78.53% | |||
inventory turnover | ||||||||||||
invested capital | -1.06 - | 0.11 - | 0.17 48.79% | 0.17 1.59% | 0.31 84.60% | 0.74 139.78% | 0.23 68.43% | -0.45 293.31% | -0.59 30.98% | |||
market cap | 49.04M - | 203.11M 314.12% | 170.23M 16.18% | 150.69M 11.48% | 119.01M 21.02% | 60.80M 48.91% | 114.95M 89.08% | 83.11M 27.69% | 66.62M 19.85% | 52.83M 20.69% | ||
net current asset value | -1.40M - | 19.77M 1,510.85% | 102.16M 416.83% | 86.61M 15.21% | 58.38M 32.60% | 57.16M 2.09% | 34.67M 39.34% | 7.48M 78.42% | 17.95M 139.86% | -5.40M 130.11% | -14.38M 166.24% | |
net debt to ebitda | -1.20 - | 2.77 330.89% | 3.33 20.12% | 1.96 41.16% | 1.17 40.01% | 0.96 18.03% | 1.15 19.67% | 0.39 66.13% | 1.35 246.95% | 1.06 21.93% | ||
net income per share | -0.44 - | -0.94 113.70% | -3.25 246.34% | -3.32 2.44% | -3.18 4.21% | -2.28 28.36% | -1.34 41.30% | -1.74 30.05% | -0.84 51.93% | -0.43 49.04% | ||
operating cash flow per share | -0.34 - | -0.61 77.65% | -2.62 330.83% | -2.74 4.90% | -2.85 3.89% | -2.19 23.14% | -0.95 56.52% | -1.31 37.37% | -0.48 63.26% | -0.41 15.27% | ||
payables turnover | ||||||||||||
receivables turnover | 3.77 - | 1.08 71.37% | 9.26 757.12% | 11.02 19.08% | ||||||||
research and ddevelopement to revenue | 2.22 - | 5.64 154.07% | 1.47 73.84% | 1.17 20.32% | ||||||||
return on tangible assets | -6.69 - | -0.49 92.69% | -0.29 40.07% | -0.45 53.83% | -0.71 56.59% | -0.75 5.80% | -0.58 22.10% | -1.20 106.10% | -0.58 51.33% | -0.63 7.41% | ||
revenue per share | 0.70 - | 0.29 58.44% | 0.95 225.47% | 0.92 2.62% | ||||||||
roe | 0.96 - | -0.56 158.63% | -0.31 45.03% | -0.55 76.31% | -0.93 70.77% | -1.00 6.98% | -1.06 6.17% | -6.75 537.52% | -2.04 69.87% | 10.26 604.15% | ||
roic | -12.73 - | -0.63 95.06% | -0.31 51.29% | -0.49 58.84% | -0.79 62.43% | -0.98 24.25% | -0.79 19.28% | -3.68 363.51% | -1.50 59.16% | 111.08 7,499.64% | ||
sales general and administrative to revenue | 0.78 - | 1.32 69.71% | 0.38 71.31% | 0.29 23.94% | ||||||||
shareholders equity per share | -0.46 - | 1.66 464.51% | 10.47 530.08% | 6.09 41.90% | 3.41 43.91% | 2.29 33.04% | 1.26 44.71% | 0.26 79.60% | 0.41 59.51% | -0.04 110.11% | ||
stock based compensation to revenue | 0.24 - | 0.34 39.74% | 0.08 76.11% | 0.05 32.15% | ||||||||
tangible asset value | -1.40M - | 21.10M 1,609.51% | 103.91M 392.40% | 88.18M 15.14% | 59.74M 32.25% | 59.14M 1.01% | 37.84M 36.02% | 10.71M 71.68% | 21.57M 101.33% | -2.90M 113.46% | -8.21M 182.71% | |
tangible book value per share | -0.46 - | 1.66 464.51% | 10.47 530.08% | 6.09 41.90% | 3.41 43.91% | 2.29 33.04% | 1.26 44.71% | 0.26 79.60% | 0.41 59.51% | -0.04 110.11% | ||
working capital | 82K - | 19.80M 24,046.34% | 102.24M 416.38% | 96.49M 5.63% | 65.58M 32.03% | 57.24M 12.73% | 35.62M 37.78% | 18.63M 47.70% | 37.68M 102.29% | 15.12M 59.87% | -6.56M 143.40% |
All numbers in USD (except ratios and percentages)